Algatech names new CEO and Chief Scientist

摘要

Algatechnologies, has announced the appointment of Ronnie Meninger as CEO. Mr. Hagai Stadler, of Grovepoint (Algatech's major shareholder) who served in the last two years as an interim CEO will become a director on the Board of Directors and will be in charge of M&A activities for Algatech. Sammy Boussiba PhD., was appointed Chief Scientist to Algatech Board of Directors. Meninger has more than 30 years of experience in the fine chemical, special ingredients and pharmaceutical industries. She served in multiple managerial positions, and was managing director of Chemada Fine chemicals, Israel (part of the ICL Croup). Meninger also is a board member of several public companies in Israel. She holds an MBA and B.Sc in Life Sciences from the Hebrew University of Jerusalem. "I'm excited to join Algatech and be part of its excellent team," says Meninger. "Our strategy for the next years includes major investments in developing unique active ingredients, incorporating innovative technologies to our cultivating process and growing through synergistic acquisitions. In addition, we will offer new delivery forms and increase our focus on compiling more comprehensive scientific data for the AstaPure~® brand in order to maintain our distinctive quality, and offer advanced natural astaxanthin solutions to our customers. We also will recruit new key positions and invest further in human resources."